NCT00303589View on ClinicalTrials.gov

A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections

PHASE2CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Soft Tissue Infections
Interventions
DRUG

Standard care

As prescribed

DRUG

beta-lactam

750mg iv q8h

DRUG

beta-lactam

1500mg iv q8h

Trial Locations (62)

1

Lima

11

Lima

1001

Riga

1002

Riga

1038

Riga

1050

Middleburg

1076

Budapest

1282

Buenos Aires

1430

Buenos Aires

1501

Benoni

1606

Sofia

1657

Buenos Aires

1684

El Palomar

1702

Ciudadela

1722

Merlo

1888

Buenos Aires

2000

Rosario

2152

Granadero Baigorria

3000

Santa Fe

3100

Entre Ríos

3402

Liepāja

4002

Plovdiv

5000

Córdoba

5800

Pleven

6020

Port Elizabeth

7130

Sommerset West

7530

Cape Town

8300

Neuquén

9000

Varna

9024

Győr

10207

Vilnius

11312

Tallinn

13419

Tallinn

23538

Lübeck

27103

Winston-Salem

32901

Melbourne

33139

Miami Beach

35209

Birmingham

36608

Mobile

48157

Münster

48201

Detroit

50009

Kaunas

51014

Tartu

55131

Mainz

55422

Minneapolis

81377

München

92288

Klaipėda

400006

Cluj-Napoca

540342

Târgu Mureş

900591

Constanța

48202-2689

Detroit

X5004CDT

Córdoba

S2000DSV

Rosario

H-1082

Budapest

04130

Vilnius

08661

Vilnius

Lima 13

La Victoria, Lima

Unknown

Lima

014461

Bucharest

041914

Bucharest

0082

Pretoria

0040

Themba

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00303589 - A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections | Biotech Hunter | Biotech Hunter